相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity
Lei Shi et al.
FEBS JOURNAL (2022)
Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death
Changfeng Li et al.
AUTOPHAGY (2021)
Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1
Bo Yan et al.
MOLECULAR CELL (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Cytochrome P450 reductase (POR) as a ferroptosis fuel
Pranavi Koppula et al.
PROTEIN & CELL (2021)
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Chao Mao et al.
NATURE (2021)
Ferroptosis, radiotherapy, and combination therapeutic strategies
Guang Lei et al.
PROTEIN & CELL (2021)
Recent progress on targeting ferroptosis for cancer therapy
Guangxiang Xu et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Xuefei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
Ling F. Ye et al.
ACS CHEMICAL BIOLOGY (2020)
AIFM2 blocks ferroptosis independent of ubiquinol metabolism
Enyong Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Yanwei Su et al.
CANCER LETTERS (2020)
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Guang Lei et al.
CELL RESEARCH (2020)
Ferroptosis-driven nanotherapeutics for cancer treatment
Xinzhu Shan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy
Tian Xu et al.
ACS NANO (2020)
GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling
Vanessa A. N. Kraft et al.
ACS CENTRAL SCIENCE (2020)
Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming
Chao Wan et al.
SCIENCE ADVANCES (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Mitochondrial Metabolism as a Target for Cancer Therapy
Karthik Vasan et al.
CELL METABOLISM (2020)
Ferroptosis and Cancer: Mitochondria Meet the Iron Maiden Cell Death
Anna Martina Battaglia et al.
CELLS (2020)
Oxidative Damage and Antioxidant Defense in Ferroptosis
Feimei Kuang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Chemically Programmed Vaccines: Iron Catalysis in Nanoparticles Enhances Combination Immunotherapy and Immunotherapy-Promoted Tumor Ferroptosis
Ane Ruiz-de-Angulo et al.
ISCIENCE (2020)
The Metabolic Underpinnings of Ferroptosis
Jiashuo Zheng et al.
CELL METABOLISM (2020)
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Iuliia Efimova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The development of the concept of ferroptosis
Tal Hirschhorn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
The release and activity of HMGB1 in ferroptosis
Qirong Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Winning the war with iron
Suzy V. Torti et al.
NATURE NANOTECHNOLOGY (2019)
Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer
Fan Zhang et al.
ACS NANO (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-1
Xuan Li et al.
JOURNAL OF INFLAMMATION-LONDON (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts
Kathinka E. Pitman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy
Xiaoqin Qian et al.
BIOMATERIALS (2019)
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Chen Liang et al.
ADVANCED MATERIALS (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
Low-Concentration PTX And RSL3 Inhibits Tumor Cell Growth Synergistically By Inducing Ferroptosis In Mutant p53 Hypopharyngeal Squamous Carcinoma
Jing Ye et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway
Zhaoyan Kong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export
Caitlin W. Brown et al.
DEVELOPMENTAL CELL (2019)
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Jose Pedro Friedmann Angeli et al.
NATURE REVIEWS CANCER (2019)
Ferroptosis promotes photodynamic therapy: supramolecular photosentizer-inducer nanodrug for enhanced cancer treatment
Ting Zhul et al.
THERANOSTICS (2019)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen et al.
ONCOGENE (2018)
The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells
Mami Sato et al.
SCIENTIFIC REPORTS (2018)
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo et al.
CANCER RESEARCH AND TREATMENT (2018)
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Amy Tarangelo et al.
CELL REPORTS (2018)
The Role of Ferroptosis in Cancer Development and Treatment Response
Bin Lu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis
Sujeong Park et al.
ANIMAL CELLS AND SYSTEMS (2018)
An Update on Immunotherapy for Solid Tumors: A Review
Toan Pham et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics
Shuaifei Wang et al.
ACS NANO (2018)
Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy
Tao Liu et al.
ACS NANO (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
The Role of NCOA4-Mediated Ferritinophagy in Health and Disease
Naiara Santana-Codina et al.
PHARMACEUTICALS (2018)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma
Weijun Ou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
Fei Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
Shumei Ma et al.
PLOS ONE (2017)
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo et al.
NATURE COMMUNICATIONS (2017)
Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
Yu Jia Wang et al.
JOURNAL OF CANCER (2017)
Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells
Chaoxiang Lv et al.
FRONTIERS IN PHARMACOLOGY (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zijian Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
An essential role for functional lysosomes in ferroptosis of cancer cells
Seiji Torii et al.
BIOCHEMICAL JOURNAL (2016)
Emerging roles for lipids in non-apoptotic cell death
L. Magtanong et al.
CELL DEATH AND DIFFERENTIATION (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis
Xiaofang Sun et al.
HEPATOLOGY (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
S. Ma et al.
CELL DEATH & DISEASE (2016)
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
Scott J. Dixon et al.
ACS CHEMICAL BIOLOGY (2015)
Glutaminolysis and Transferrin Regulate Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion
L. Sleire et al.
ONCOGENE (2015)
HSPB1 as a novel regulator of ferroptotic cancer cell death
X. Sun et al.
ONCOGENE (2015)
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Edna Ooko et al.
PHYTOMEDICINE (2015)
Artesunate Induces Cell Death in Human Cancer Cells via Enhancing Lysosomal Function and Lysosomal Degradation of Ferritin
Nai-Di Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Scott J. Dixon et al.
ELIFE (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Metabolic Regulation by p53 Family Members
Celia R. Berkers et al.
CELL METABOLISM (2013)
NADPH-Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology
David S. Riddick et al.
DRUG METABOLISM AND DISPOSITION (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
System xc- and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency
Pankaj Kumar Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
Hua Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
B. Combe et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The x c - cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Jun Guan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells
Wan Seok Yang et al.
CHEMISTRY & BIOLOGY (2008)
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels
Nicholas Yagoda et al.
NATURE (2007)
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinorna cells expressing AXL
Jong-Ding Lay et al.
CANCER RESEARCH (2007)
Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein α by phosphatidylinositol 3-kinase signaling cascade
Jharna Datta et al.
CANCER RESEARCH (2007)
Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: Enhancement of growth-inhibitory activity of doxorubicin
Vishal S. Narang et al.
CHEMOTHERAPY (2007)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Molecular characterization of the cystine/glutamate exchanger and the excitatory amino acid transporters in the rat lens
J Lim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis
M Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
分享论文
